AnaptysBio Inc (ANAB)
20.23
-1.45
(-6.69%)
USD |
NASDAQ |
Nov 04, 13:00
AnaptysBio Max Drawdown (5Y): 90.03% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 90.03% |
September 30, 2024 | 90.03% |
August 31, 2024 | 92.08% |
July 31, 2024 | 92.08% |
June 30, 2024 | 92.08% |
May 31, 2024 | 92.08% |
April 30, 2024 | 92.08% |
March 31, 2024 | 92.08% |
February 29, 2024 | 92.08% |
January 31, 2024 | 92.08% |
December 31, 2023 | 92.08% |
November 30, 2023 | 92.08% |
October 31, 2023 | 92.08% |
September 30, 2023 | 92.08% |
August 31, 2023 | 92.08% |
July 31, 2023 | 92.08% |
June 30, 2023 | 92.08% |
May 31, 2023 | 92.08% |
April 30, 2023 | 92.08% |
March 31, 2023 | 92.08% |
February 28, 2023 | 92.08% |
January 31, 2023 | 92.08% |
December 31, 2022 | 92.08% |
November 30, 2022 | 92.08% |
October 31, 2022 | 92.08% |
Date | Value |
---|---|
September 30, 2022 | 92.08% |
August 31, 2022 | 92.08% |
July 31, 2022 | 92.08% |
June 30, 2022 | 92.08% |
May 31, 2022 | 92.08% |
April 30, 2022 | 92.08% |
March 31, 2022 | 92.08% |
February 28, 2022 | 92.08% |
January 31, 2022 | 92.08% |
December 31, 2021 | 92.08% |
November 30, 2021 | 92.08% |
October 31, 2021 | 92.08% |
September 30, 2021 | 92.08% |
August 31, 2021 | 92.08% |
July 31, 2021 | 92.08% |
June 30, 2021 | 92.08% |
May 31, 2021 | 92.08% |
April 30, 2021 | 92.08% |
March 31, 2021 | 92.08% |
February 28, 2021 | 92.08% |
January 31, 2021 | 92.08% |
December 31, 2020 | 92.08% |
November 30, 2020 | 92.08% |
October 31, 2020 | 92.08% |
September 30, 2020 | 92.08% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
90.03%
Minimum
Sep 2024
92.08%
Maximum
Nov 2019
92.01%
Average
92.08%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
Regeneron Pharmaceuticals Inc | 43.25% |
Ligand Pharmaceuticals Inc | 76.91% |
Agios Pharmaceuticals Inc | 82.86% |
ADMA Biologics Inc | 84.77% |
Black Diamond Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -9.732 |
Beta (5Y) | -0.2446 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.37% |
Historical Sharpe Ratio (5Y) | -0.2067 |
Historical Sortino (5Y) | -0.5186 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.23% |